Home › Trial NCT02535104
Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
- Trial IDNCT02535104
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorTamir Biotechnology, Inc.
- Enrollment70
- Start date2016-02
- ConditionsCondylomata Acuminata · Papillomavirus Infections · Sexually Transmitted Diseases
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.